T6神经损伤平面判定自主神经反射异常风险的不可靠性
横断面研究纳入138例脊髓损伤患者,比较T6及以上与以下损伤平面者症状性自主神经反射异常(AD)的发生率。结果显示T6以上者77%、T6以下者38%出现症状性AD,实验室测试中两组均为57%,提示T6平面不能可靠区分AD风险。
要点
- T6及以上脊髓损伤者症状性AD发生率为77%,T6以下者为38%。
- 实验室诱发测试中,T6及以上与以下损伤者AD发生率均为57%。
- T6以下损伤者AD可能与血管反应性增高和压力反射敏感性降低有关。
核心结论
- 症状性和客观AD在T6神经损伤平面以上和以下的脊髓损伤者中均可发生。
- T6平面阈值不能可靠区分谁会发生症状性AD,临床应避免使用这一严格 cutoff。
研究设计与样本
- 横断面研究,纳入138例有/无脊髓损伤者,其中34例未损伤对照和28例脊髓损伤者完成深入自主神经生理学表征。
主要发现
- 脊髓损伤后AD症状显著高于未损伤对照(p < .001)。
- 症状性AD在T6及以上脊髓损伤者中占77%,在T6以下者中占38%。
- McNemar统计量提示T6神经平面区分症状性AD的能力较差(p = .039)。
- 实验室测试中,T6及以上者57%发生AD,T6以下者亦57%(p = .33)。
- T6以下脊髓损伤者的AD可由血管反应性增高和压力反射敏感性降低导致,伴代偿性心动过缓轻微。
临床怎么用
- 临床不应仅凭T6神经损伤平面判断AD风险,需结合针对性自主神经测试。
- 对T6以下脊髓损伤者也应警惕症状性和客观AD的发生。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Abstract Background The T6 neurological level of spinal cord injury (SCI) is classically taught as differentiating who is and is not at risk for autonomic dysreflexia (AD); yet the reliability of this metric has rarely been tested. Objectives To determine how often individuals with SCI above and below the T6 neurological level of injury (NLI) experience symptomatic AD, quantify AD in the autonomic physiology laboratory, and describe underlying mechanisms that clinically manifest. Design Cross-sectional. Setting Academic medical center. Participants 138 individuals with/without SCI. Interventions Not applicable. Main Outcome Measures Symptoms of AD were quantified using the validated Autonomic Dysfunction Following SCI-AD survey. Deep autonomic physiology characterization was further completed (n = 34 uninjured controls, n = 28 individuals with SCI) to identify underlying AD mechanisms. Continuous blood pressure, heart rate, regional vascular resistance in the arm/leg, and pre/posttest catecholamines were recorded. Vascular responsiveness and baroreflex sensitivity were assessed with intravenous phenylephrine boluses. Foot cold pressor and bladder pressor tests served as below level mild noxious stimuli to elicit controlled AD. Results AD symptoms were, as expected, significantly higher after SCI compared to uninjured controls (p < .001). Symptomatic AD was identified in 77% of individuals with SCI at/above T6, compared to 38% with injuries below T6. McNemar's statistic indicated the T6 neurological level poorly differentiated who developed symptomatic AD (p = .039). During laboratory testing, 57% of those with SCI at/above T6 experienced AD, as did 57% of those with injuries below T6 (p = .33). Physiologically, AD in individuals with SCI below T6 can be due to heightened vascular responsiveness and poor baroreflex sensitivity, leading to minimal compensatory bradycardia. Conclusions Symptomatic and objective AD occurs in those with SCI above and below the T6 NLI threshold. As such, targeted autonomic testing must translate to the bedside to accurately quantify AD risk. In the interim, though the T6 threshold has become cannon in many patient and resident education materials regarding AD risk, evidence suggests clinical care should avoid using this strict cutoff.
引用
- PM&R:The fallibility of the T6 neurological level of injury for determining autonomic dysreflexia risk
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。